Upcoming Classes

STI INTENSIVE COURSE (Virtual)

December 2nd, 3rd, and 4th 2025 8:45 AM-12:30 PM EST EACH DAY

The STI Intensive Course is a three 1/2-day didactic virtual course which provides registered participants with training in the most recent advancements in sexual history taking, the diagnosis and management of viral and bacterial STIs, and STI & HIV prevention.

Target Audience: Physicians, physician assistants, nurse practitioners, nurses, and other clinical healthcare professionals who see patients with or who may acquire sexually transmitted infections (STIs). Free CME/CNE is offered for this course. 

Registration required. You must register for all three days; CME/CNE is offered for attendance at all three days only. 

Agenda

December 2nd

December 3rd

December 4th

This session will review new CDC 2024 DoxyPEP guidelines, identifying patient populations most likely to benefit from DoxyPEP.  The session will discuss pros and cons of DoxyPEP including resistance concerns, and review advances in STI diagnosis and treatment and their clinical implications. 

STI Overview

OBJECTIVES 

1.  Describe most recent epidemiology for reportable STIs in the United States and locally

2.  Identify the common bacterial or antibiotic treated STIs

3.  Identify the common viral STIs

4.  Describe at least 2 population factors increasing one's risk for acquisition of an STI

5.  Discuss provider skills in sexual health services3.  Identify the common viral STIs

6.  Describe the importance of interprofessional collaboration in health department and

private practice regarding STIs

CME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Alabama Marnix E. Heersink School of Medicine and the STD/HIV Prevention Training Center at Johns Hopkins. The University of Alabama Heersink School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Alabama Heersink School of Medicine designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Shanna Dell would like to disclose that her agency gets money from Gilead Pharmaceuticals. Dr. Khalil Ghanem would like to disclose that he gets royalties from UpToDate.  Lee Gilman would like to disclose that he receives an honorarium from CME Outfitters.  All other speakers do not have anything to disclose

There is no commercial support for this activity. 

CNE

This nursing continuing Professional Development activity was approved by the Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

There are 16.5 nursing contact hours awarded for those who attend the entire program as well as complete the evaluation for this program.

Lee Gilman would like to disclose that he receives an honorarium from CME Outfitters.

None of the planners for this activity have relevant financial relationship(s) with ineligible companies to disclose.

Pleasure Principles Round Table

This course will take place on December 10th, from 12:00 PM - 1:00 PM CST

Target Audience: Physicians, PAs, NPs, nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs)

Course Description: Expect to participate in a discussion surrounding the role of Pleasure in the Sexual Health Clinic atmosphere. Examples of how to speak with patients and how to understand their sexual health goals will be brought up, but we encourage you all to bring thoughts & concerns of your own. The intent is to create a collaborative community- in other words, we want YOU to bring your cases and contribute topics. The sessions will be organized and moderated by the St. Louis STI/HIV PTC but the floor will be open for discussion and participation. You will be interacting with other clinical colleagues (physicians, PAs, NPs, nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs)MD, DO, PA, NP, RN) from other health department clinics. We may even have a little friendly competition.

The Clinical eLearning Community will be held virtually on Zoom.

For questions, please contact: Sarah Alsop at alsop@wustl.edu

Designation Statement: The St. Louis STI/HIV Prevention Training Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The St. Louis STI/HIV Prevention Training Center can only provide CME for MDs/DOs, all other participants will receive a Certificate of Participation

Accreditation Statement: The St. Louis STI/HIV Prevention Training Center is accredited by the Nebraska Medical Association to provide continuing medical education for physicians.

 Screen, Diagnose, Treat: Responding to Syphilis in Oklahoma offers an overview of current syphilis trends and priority concerns across the state. Participants will learn screening, diagnostic, and treatment practices grounded in the latest evidence. This session provides practical guidance to help providers strengthen prevention efforts and improve patient outcomes. 

Learning Outcomes:

Participants will demonstrate increased knowledge and confidence in identifying, diagnosing, managing, and treating syphilis across various populations, thereby improving overall prevention and health outcomes in their communities.

Learning Objectives: 

• Describe the national and local epidemiology and trends of syphilis in Oklahoma.
• State the current recommendations for syphilis screening, including considerations for pregnant persons and other priority populations.
• Discuss evidence-based approaches for the diagnosis, management, and treatment of syphilis.
• Identify key strategies and action steps for healthcare providers to reduce syphilis transmission and improve linkage to care and treatment outcomes.

Date: December 11th, 2025

Time : 7:00AM-8:15AM CST

Location: Will be sent after registration in confirmation email. 

This 90-minute training explores the intersection of substance use disorders (SUD) and sexually transmitted infections (STIs) in Louisiana. Participants will gain insights into current trends in opioid, fentanyl, and methamphetamine use, and how these patterns influence STI risk and outcomes in Louisiana. The session highlights harm reduction strategies, community resources, as well as stigma reduction approaches for providers and frontline staff. A panel of will share perspectives from the field, including disease intervention specialists and harm reduction teams, equipping attendees with practical tools to address SUD and STI challenges in their communities.

Learning Objective

• Examine the intersection of substance use disorders (SUD) and sexually transmitted infections (STIs) in Louisiana, with emphasis on harm reduction, stigma reduction, and clinical/provider awareness.

Learning Outcomes

By the end of this training, participants will be able to:

1. Identify key factors contributing to the overlap between SUD and STI transmission, acquisition, and treatment within Louisiana.
2. Apply harm reduction strategies and community resources to better support individuals with SUD and reduce barriers to STI prevention and care.

STI Expert Hour Webinar - Male Partner Treatment to Prevent BV Recurrence: Evidence and Implementation

December 18, 2025

1:30p.m. - 2:50p.m.

1.25 CME units at no cost

Registration closes on December 17, 2025 at 3:00PM (PST).

Presenter

Catriona Bradshaw, MMBS(Hons), FAChSHM, FAHMS, PhD

Professor

Melbourne Sexual Health Centre, Alfred Health

School of Translational Medicine, Monash University

Melbourne School of Population and Global Health, University of Melbourne

Course Description

This seminar will discuss the epidemiological and microbiological evidence and pilot data that led to the StepUp randomised controlled trial (RCT) - an RCT that demonstrated treating male partners with a combination of oral and topical antimicrobials at the time a women is being treated for bacterial vaginosis (BV) significantly improved cure over 12 weeks. The trial methodology and findings will be presented in detail. The seminar will have a focus on the practicalities of implementation and prescribing including examples of free online resources available to assist clinicians in discussing and providing partner treatment for BV, consumer resources to assist informed decision making, and qualitative research findings. Time will be made available for audience discussion and participation. 

Learning Objectives

• Participants will be able to understand the rationale and evidence for male partner treatment for BV and apply this new knowledge to their clinical practice. 
• Participants will be able to discuss partner treatment for BV with their patients, facilitate shared decision making, understand where to access evidence-based resources, and make informed decisions regarding the provision of this intervention for heterosexual couples.

Registration Confirmation with Zoom Webinar Link

Within 24 hours of registering: 

• You will receive the NNPTC registration confirmation email from training@nnptc.org sent to the email you used to register with for the webinar on NNPTC.
• The registration confirmation email will include the Zoom webinar link.
• Please review the Zoom webinar link instructions and other webinar details prior to joining the webinar.
• We ask that you do not share or forward any links associated with the webinar.
• Those not registered on NNPTC who sign on to the webinar will not be counted in attendance or eligible to receive CME credit. 
• To ensure you receive the NNPTC registration confirmation, please add training@nnptc.org to your safe/trusted senders list and be sure to monitor both your Inbox and spam/junk folders for the notification.

ACCME Disclosure

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nevada, Reno School of Medicine and California Prevention Training Center. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians. The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement. Nurses should check with their individual licensing boards to confirm the acceptability of AMA credits for the purpose of licensing renewal.

Financial Disclosure

As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of a continuing medical education activity disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.